Class 4 caution in use-Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg Capsules

Jubilant Pharmaceuticals BV has informed the MHRA that the outer carton (box) of the product batches mentioned in this notification are missing the medicines legal classification for a Prescription Only Medicine ‘POM’. There is no risk to product quality or safety of the medicines.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-pregabalin-25mg-50mg-75mg-100mg-150mg-200mg-225mg-300mg-capsules-jubilant-pharmaceuticals-nv-el-25-a-slash-19?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=0511c50f-94f9-492c-a7cb-e9451ffcc68f&utm_content=immediately

MHRA drug alert date: 29/04/25

This is a caution in use only we are not accepting stock returns

Further Information

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Class 4 caution in use-PI Brilique 90mg Tablets

G Pharma Ltd have informed the MHRA that there is an error in the spelling of the active ingredient included on the imported carton. The spelling should be ‘Ticagrelor’ but has been printed as ‘Tricagelor’ under the brand name and in the content statement.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-brilique-90mg-tablets-el-25-a-slash-18?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=338050a1-7c68-4c7d-9ebb-14fee1ccad21&utm_content=immediately

MHRA drug alert date: 24/04/25

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries please email ddavies@gpharma.co.uk, or telephone 0161 888 7317. For stock control enquiries please email ddavies@gpharma.co.uk or telephone 0161 888 7317.

Class 2 recall-Lercanidipine HCl 20mg Tablets

We have received a Class 2 Recall from Recordati Industria Chimica e Farmaceutica S.p.A. on Lercanidipine HCl 20mg Tablets.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-lercanidipine-hcl-20mg-tablets-recordati-industria-el-25-a-slash-17?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=070d68eb-f056-4249-95fe-9701644771a1&utm_content=immediately

DMRC Ref: 35334038

Reason: “Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of Lercanidipine HCl 20mg Tablets. The packs are incorrectly labelled as 10mg on some sides of the product carton when they are 20mg tablets.”

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, please email medinfo@recordati.co.uk, or telephone +353 (0)87 6245669. For stock control enquiries please email customerservice@recordati.com, or telephone 01491 576 336.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification (17/04/2025), cannot be reimbursed by way of a credit.

Early May 2025 bank holiday opening hours

To help keep our customers informed of changes to our service, we have published our Early May 2025 bank holiday opening hours for pharmacy and retail customers.

Early May 2025 bank holiday opening hours

Early May 2025 bank holiday opening hours (for Channel Islands and Isle of Man)

Class 2 recall-Synalar 30g & 60g gel

It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of 2ppm. Reig Jofre UK are recalling the batches as a precautionary measure. This recall is at the pharmacy and wholesaler level.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-synalar-gel-30g-synalar-gel-60g-fluocinoline-acetonide-0-dot-025-percent-reig-jofre-uk-el-25-a-slash-16?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=6cd7db97-6cc0-4a89-b429-009bf1866ec6&utm_content=immediately

MHRA ref:DMRC-35165402

Further Information

For medical information enquiries please contact Reig Jofre UK Medical Information on 0330 1359 434 or by email MedInfoUK@reigjofre.com.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Renacet 465 & 950 mg tablets

RenaCare NephroMed GmbH has informed the MHRA of the presence of an undeclared excipient in the coating of the tablets. This excipient is Macrogol 6000, which has always been included in Renacet Tablets but has been omitted from the list of excipients in error.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-renacet-475-mg-and-950-mg-tablets-calcium-acetate-renacare-nephromed-gmbh-el-25-a15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=23366ae3-59e2-40b3-aa14-5d94fd8c2381&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk

For stock control enquiries telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk

Class 3 recall-Urospir 50mg/5ml solution

Rosemont Pharmaceuticals Limited is recalling a single batch of Urospir 50mg/5ml Oral Solution (spironolactone) as a precautionary measure. The recall is due to errors in some of the dose calculation in millilitres being stated incorrectly in the SmPC and PIL.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-urospir-50mg-slash-5ml-oral-solution-el-25-a-slash-14?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9691ad0b-c6c7-495b-b16f-dd6e46fd62a0&utm_content=immediately

MHRA ref: DMRC-35150350

Further Information

For all medical information enquiries and information on this product, please contact pharmacovigilance@rosemontpharma.com, or telephone 0113 244 1400. For stock control enquiries please contact customerservices@rosemontpharma.com, or telephone 0113 244 1999.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-PI Utrogestan 200mg capsules

Uni Health Distribution Ltd has informed the MHRA of a typographical error on the approved carton overlabel for certain batches of Utrogestan Vaginal 200 mg Capsules. The carton label references ‘micrograms’ where it should actually state ‘milligrams’.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-utrogestan-vaginal-200-mg-capsules-progesterone-el-25-a-slash-13?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=e74c1d0f-d431-4333-a97c-c6a1841f0ae1&utm_content=immediately

MHRA ref:DMRC-35159465

Further Information

For further information and all enquiries please contact info@uhdltd.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-PI sirdupla 25/250mcg

Cross Healthcare Limited have informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension, batch 77518.

MHRA Drug alert date: 31st March 2025

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-sirdupla-25-microgram-slash-250-microgram-per-metered-dose-pressurised-inhalation-suspension-el-25-a-slash-12?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d22cb799-f4af-4d08-9ede-bec4f9f733fa&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For further information please email gary@crosshealthcare.co.uk or telephone 01786 817707.

Easter Bank Holiday Opening Hours 2025

To help keep our customers informed of changes to our service, we have published our Easter 2025 bank holiday opening hours for pharmacy and retail customers.

Easter Bank Holiday Opening Hours 2025

Channel Islands and Isle of Man Easter Bank Holiday Opening Hours 2025

Cavendish Easter BH opening hours 2025